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W e e x a m l n e d t h e e f f e c t s of maternal treatment w i t h t h e n o n -h a l o g e n a t e d t h y r o l d analog, 3 , 5 -d i m e t h 1 3 ' -so r o p y 1 t h y r o n i n e (DlMIT,O.b uq11ooqm1dY t o rats wRose f e t u s e s h a d b e e n r e n d e r e d h y p o t h y r o l d (HYPO-Tx) b y maternal r o p y l t h l o u r a c l l . N e o n a t a l u p s w e r e s a c r l t l c e d a n d Piver rnlcrosomes p r e p a r e d For assessment o* UDPGT-ase a c t l v r t y nMlmg1mln).
Membrane t l u l d l t y w a s d e t e r m i n e d b y f l u o r e s c e n c e o l a r l z a t o n ( F P ) EONTROL HYPO-+x HYPO This c o n t r o l led, double-blind. study assessed t h e r e n a l impact of e a r l v (< 12 hr Dostnatal age) indomethacin [I] . f o r reve en ti on of p a t e i t ductus G t e r i o s u s (FDA), i n 02 dependent inbdrn i n f a n t s with b i r t h wei h t s (BW)<1300 gm. F i f t y i n f a n t s randomly received 3 IV doses of [I? o r placebo [PI a t 12 h r i n t e r v a l s . Dose1 (Ill) was 0.2 mg/kg;D2 and were 0.1 mg/kg each. F l u i d balance, serum sodium (Na). potassium (K), c r e a t i n i n e (Cr), blood urea nitrogen (BUN) and f r a c t i o n a l Na excretion (FPNa) were e v a l u a t e d pre-Dl.
6-12 h r ~o s t -D l . 12-36 h r oost-D?. and 1 wk oost-Da. Timed u r i n e specimen; were used t o d e r i v e c r d i l e a r a n c e (co) p;st-D3 and 1 wk post-D3. The 25 i n f a n t s i n each group were comparable i n BWI g e s t a t~o n a l age, APGARs, pH and base excess a t study entry.
[I]-t r e a t e d i n f a n t s had reduced u r i n e output (UO) i n the 12 h r period following D l t h a t was no longer e v i d e n t post-D3. F l u i d intake. Na. K. BUN. Cr.PENa, and CCr were s i m i l a r throughout t h e study. 59.6 + 3.6 c o n t r o l s . ~r e n a t a l ' t r e a t m e n t w l t h UlMlT s!imulated 
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b e r e v e r s e d b y p r e n a t a l r e a t m e n t w i t h DIMlT a I n c o n t r a s t t o r e p o r t s of r e n a l dysfunction induced by indot h y r o l d a n a l o g w h l c h r e a d l l y crosses t h e p l a 6 e n t a .
methacin therapy f o r symptomatic PDA, e a r l y [ I ] appears t o a l t e r r e n a l function minimally i n prematures without s i g n i f i c a n t PDA.
COMPARATIVE EFFECTS OF ACUTE HYPOXEMIA (H) O N CARDIOVASCULAR RESPONSES TO DOPAMINE (Dp), DOBUTAMINE
~L~~L P e t e r s o n~~ g = S U N Y a t Stony Brook, H e a l t h S c i e n c e s C e n t e r , S c h n e l d e r Children's H o s~i t a l . Deot. of P e d i a t r i c s . New Hvde Park. NY.
Two week o i d p i g l e t s were a n e s t h e t i z e d a n i v e n t i l a t e d ; t h e ductus a r t e r i o s u s was ligated. ECG, a o r t i c (AO) and LV pressures (PI, LV d P / d t max, and p h a s i c pulmonary ( c a r d i a c o u t p u t , CO)
, m e s e n t e r i c (Mes) and r e n a l ( R e d f l o w s (F) were reoorded. S e q u e n t i a l 10 m i n i n f u s i o n s o f I p ( n = 8 ) 0.05, 0.1, 0.2 mcg/kg/min, Dp (n.6) 2, 5, 15 o r Db (n.7) 2, 5, 15 mcg/kg/min were g i v e n d u r i n g normoxemia (NO; PO2 103&4 mmHg) and r e p e a t e d during H (PO 39k1 mm Hg). I n 8 age-matched c o n t r o l s s a l i n e was infused and 2no s i g n i f i c a n t (NS) ohanges observed.
Mean percent LV dP/dt max d u r i n g H, w h i l e I p d i d not. Db i n c r e a s e d CO, b u t i n c r e a s e s i n i n o t r o p y w e r e a t t e n u a t e d d u r i n g H. 2) C h r o n o t r o p i c e f f e c t s of a l l t h r e e d r u g s were a t t e n u a t e d by H. 3 ) P e r i p h e r a l v a s c u l a r e f f e c t s d u r i n g N O were n o t s u s t a i n e d d u r i n g H by any drug. 4 )
The d a t a s u g g e s t t h a t Dp i s most, and I p i s l e a s t e f f e c t i v e i n e l i c i t i n g b e n e f i c i a l c a r d i a c responses i n hypoxic newborns. P r e n a t a l exposure t o 6-adrenergic a g o n i s t s , such as t e r b u t a l i n e ( T ) , augments s u r f a c t a n t r e l e a s e in r a b b i t f e t u s e s . The impact of p o s t n a t a l (T) administration t o prematurely delivered r a b b i t pups, however, remains l a r g e l y unexplored. W e postulated t h a t s u r f a c t a n t r e l e a s e would a l s o occur with p o s t n a t a l (T). To explore t h i s , premature r a b b i t pups of known g e s t a t i o n (28-30d) were randomized a t d e l i v e r y i n t o (T) or placebo (P) groups. (T) (5.8-8.8 mglkg) or (P) was i n j e c t e d i . p . within 5 min of d e l i v e r y . Thirty min a f t e r i n j e c t i o n , pups were s a c r i 
f i c e d and evaluated f o r t o t a l lung capacity (TLC), lung d e f l a t i o n s t a b i l i t y , and lung lavage d i s a t u r a t e d phosphatidyl choline (DSPC). (TI and (P) pups had s i m i l a r birthweights, surv i v a l c h a r a c t e r i s t i c s , TJX, and dry lung weights (DLW). 28d (T) pups demonstrated improved d e f l a t i o n s t a b i l i t y a t 7

t i o n s t a b i l i t y i n d i s t i n g u i s h a b l e from ( P ) . Our r e s u l t s suggest t h a t p o s t n a t a l (T)
augments s u r f a c t a n t r e l e a s e i n prematurely delivered r a b b i t s , and may suggest a f u t u r e r o l e for e a r l y 0-adrenergic therapy of hyaline membrane disease. 
ONTOGENY OF RAT LIVER MICROSOMAL UDP-GLUCURONOSYL t 407 TRANSFERASE (UDP-GT) ACTIVITY TOWARD FUROSEMIDE(F)
A
Disposition of F depends on i t s r e n a l t u b u l a r s e c r e t i o n and i t s metabolic conjugation with glucuronic a c i d . I t has been suggested t h a t decreased F clearance i n the neonatal period i s due t o immaturity of t h e s e d i s p o s i t i o n a l pathways. The development of UDP-GT a c t i v i t y i n the p e r i n a t a l period f a l l s i n t o two s u b s t r a t e s p e c i f i c groups: a " l a t e f e t a l " group of a c t i v it i e s t h a t a t t a i n a d u l t l e v e l s j u s t before term and an "early neonatal" group t h a t shows minimal a c t i v i t y during pregnancy but increases r a p i d l y a f t e r b i r t h .
The " l a t e f e t a l " group c o r r e l a t e s with a c t i v i t i e s t h a t a r e induced by 3-methylcholanthrene (~M c ) type inducers while the "early neonatal" group c o r r e l a t e s with phenobarbital (Pb) induction i n a d u l t r a t s . We have studied the ontogeny and i n d u c i b i l i t y of UDP-GT a c t i v i t y toward F (F-UDP-GT) i n f u l l y a c t i v a t e d r a t l i v e r microsomal preparations.
During days 18 and 20 of g e s t a t i o n and t h i r d and s i x t h p o s t n a t a l days, l i v e r F-UDP-GT a c t i v i t i e s were 3%, 9%, 57% and 80% of a d u l t a c t i v i t y (373+21 pmoleslmg proteinlmin), r e s p e c t i v e l y .
After treatment of a d u l t r a t s with F, Pb, 3MC o r pregnenolone-16-alpha-carbonitrile (PCN), F-UDP-GT a c t i v i t y was 310+241 617+84$ 8645185 and 1010273 pmoleslmg proteinlmin respectively: I t i s concluded t h a t F-UDP-GT a c t i v i t y develops i n the e a r l y neonatal period, and i s inducible by not only Pb, but even more so by 3MC and PCN.
VITAMIN E CONTENT OF TISSUES OBTAINED FROM HUMAN INFANTS GIVEN PHARMACOLOGIC DOSES OF TOCOPHEROL OR
408 TOCOPHERYL ACETATE INTRAVENOUSLY. Med., Iowa C i t y , Iowa, C e n t e r s f o r D i s e a s e C o n t r o l , A t l a n t a , Univ. of R o c h e s t e r Med. Ctr., R o c h e s t e r , N.Y., Univ. of Tenn. Memorial Hosp., K n o x v i l l e , Good S a m a r i t a n Hosp., Cinn., Univ. I l l i n o i s Hosp., Chicago.
Tissues obtained from i n f a n t s who had received varying doses of v i t a m i n E were a n a l y z e d f o r t o c o p h e r o l (T) and t o c o p h e r y l a c e t a t e (TA) c o n t e n t by HPLC. I V a d m i n i s t r a t i o n of TA(27-48 Ulkglday f o r 9-42 days) r e s u l t e d i n l i v e r TA l e v e l s from 30-500 ug/g and T l e v e l s from 0-4135 ug/g. TA and T l e v e l s i n kidney t i s s u e ranged from 0-36 ug/g and 0-189 ug/g, r e s p e c t i v e l y . The method of t i s s u e p r e s e r v a t i o n employed ( t y p e of f i x a t i v e , s t o r a g e temperature) may account f o r t h e lower range of TA and T v a l u e s observed i n these tissues.
Lower I V doses of TA (3-6 Ulday f o r 21-52 days) r e s u l t e d i n l e v e l s of TA i n l i v e r of 0-27 uglg and T l e v e l s of 12-30 ug/g. One i n f a n t g i v e n a s i n g l e 20 mglkg IV d o s e of T 3 h r s p r i o r t o d e a t h had 382 u g l g of T i n the l i v e r and no TA. I n f a n t s given o n l y n u t r i t i o n a l amounts of T o r TA o r a l l y (2-25 Ulday) have T l e v e l s of l e s s than 20 uglg i n the l i v e r , kidney, and lung.
These r e s u l t s i n d i c a t e t h a t t h e amounts of T and TA a r e s i g n i f i c a n t l y increased i n t i s s u e s , p a r t i c u l a r l y t h e l i v e r , i n i n f a n t s r e c e i v i n g pharmacologic doses of TA intravenously. The s i g n i f i c a n c e of T and TA t i s s u e l e v e l s r e l a t i v e t o e f f i c a c y o r t o x i c i t y of v i t a m i n E t h e r a p y i n i n f a n t s remains t o be ~s t a b l i s h e d .
